In silico pathway analysis of MAPKs and computational investigation of bipyrazole analogues as novel p38alpha MAPK inhibitors Online publication date: Sat, 19-Mar-2016
by Deepak Nedunuri; Yesu babu Adimulam; Kiran Kumar Reddi
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 12, No. 1, 2016
Abstract: Mitogen-Activated Protein Kinase (MAPK) belongs to one of the largest super-families of proteins. The activity of most MAPKs is stimulated by a large variety of signals, including mitogens, growth factors, cytokines, T-cell antigens, pheromones, UV and ionising radiations, osmotic stress, heat shock, oxidative stress and others. The present work determines the participation of particular MAPK to one specific pathway in the MAPKinase signalling (MAPK 1-14). Various computational analyses involving Clustal omega, phylogenetic tree reconstruction and ProDom have been utilised in the study. Based on evolutionary relationships, domain detections and comparison of active site residues, the specificity of MAPKs in defined pathways is emphasised. MAPKs have been shown to play a pivotal role in diverse diseases, including cancer. Majority of studies have focused on targeting p38 MAPK isoform alpha (MAPK14). Hence, in this paper we elucidate a computational mechanism of inhibition by bipyrazole analogues, for the first time, as promising inhibitors of p38alpha MAPK.
Online publication date: Sat, 19-Mar-2016
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com